Monitor for additional insider selling in coming weeks — isolated small sales by non-CFO/CFO-level executives are typically routine, but sustained selling could signal concern. No immediate trading signal.
Price Chart
Executive Summary
Krystal Biotech CEO Krishnan Krish and Chief Accounting Officer Kathryn Romano sold shares in the open market, totaling $324,982 in proceeds over the past week. These were open-market sales by two executives, with the CEO selling 483 shares and the CAO selling 750 shares at prices between $257 and $268.
Key Financial Metrics
Key Facts
- CEO Krishnan Krish sold 483 shares at $257.31, totaling $124,282 in open-market transaction on March 4, 2026.
- Chief Accounting Officer Kathryn Romano sold 750 shares at $267.60, totaling $200,700 in open-market transaction on March 2, 2026.
- Total open-market sales by insiders in the past 7 days: $324,982.
- Sales represent approximately 0.0043% of Krystal Biotech's $7.6B market cap — well below the 0.1% threshold for materiality.
Financial Impact
$324,982 in total open-market sales by two executives; less than 0.01% of market cap
Risk Factors
- Perception of insider selling, even if immaterial, could weigh on sentiment if highlighted by retail investors.
- Future sales at higher volume or by additional C-suite members could indicate deeper concerns.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (2 trades, 7d window) | cluster-KRYS-1772839375312 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 27d ago | Insider Cluster | $351.26 $336.68 | ▲ +4.15% | ▲ +3.03% | $322.28 (+8.25%) |
Aug 14, 2026 7w ago | 144 | $335.73 $341.72 | ▲ +1.78% | ▲ +2.97% | $322.28 (−4.01%) |
Aug 3, 2026 8w ago | 8-K | $312.57 $331.59 | ▲ +6.08% | ▲ +4.06% | $322.28 (+3.11%) |
Jul 23, 2026 10w ago | Press Release | $335.19 $366.85 | ▲ +9.45% | ▲ +9.07% | $322.28 (−3.85%) |
Jun 5, 2026 17w ago | Insider Cluster | $301.76 $324.75 | ▲ +7.62% | ▲ +5.51% | $322.28 (+6.80%) |
May 4, 2026 21w ago | Press Release | $286.95 $312.88 | ▲ +9.04% | ▲ +6.10% | $322.28 (+12.31%) |
Apr 21, 2026 23w ago | Press Release | $272.66 $269.27 | ▼ −1.24% | ▼ −2.33% | $322.28 (+18.20%) |
Apr 3, 2026 26w ago | DEFA14A | $261.80 $267.41 | ▲ +2.14% | ▼ −1.99% | $322.28 (+23.10%) |
Feb 27, 2026 31w ago | Insider Cluster | $275.64 $253.69 | ▼ −7.96% | ▼ −5.98% | $322.28 (+16.92%) |
Feb 27, 2026 31w ago | Insider Cluster | $275.64 $253.69 | ▼ −7.96% | ▼ −5.98% | $322.28 (+16.92%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access